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Objective: The optimal treatment of patients with acute type B dissections continues
to be debated.
Methods: A 36-year clinical experience of medical and surgical treatments in 189
patients was retrospectively analyzed (multivariable Cox proportional hazards
model) with respect to three outcome end points: all deaths, freedom from reop-
eration, and freedom from late aortic complications or death. Propensity score
analysis identified 2 quintiles (quintiles I and II, consisting of 142 comparable
patients) for further comparison of the effects of surgical versus medical
treatment.
Results: Shock (hazard ratio 14.5, 95% confidence interval 4.7-44.5, P  .001) and
visceral ischemia (hazard ratio 10.9, 95% confidence interval 3.9-30.3, P  .001)
largely predominated as determinants of death, along with 6 other risk factors (arch
involvement, rupture, stroke, previous sternotomy, and coronary or lung disease),
which roughly doubled the hazard of death. Female sex was a significant but weaker
predictor of death. Renal dysfunction, year of presentation, age, and mode of
therapy (medical vs surgical) had no important bearing on overall survival. The
actuarial survival estimates for all patients were 71%, 60%, 35%, and 17% at 1, 5,
10, and 15 years, respectively, and were similar for the medical and surgical
patients. Reoperation and late aortic complications were predicted by the presence
of Marfan syndrome. For the propensity-matched patients in quintiles I and II,
survival, freedom from reoperation, and freedom from aortic complications were
almost identical in the medically treated and surgical subsets.
Conclusions: The prognosis for patients with acute type B aortic dissection is bleak
and determined primarily by dissection-related and patient-specific risk factors,
which do not appear to be readily modifiable.
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Consensus exists regarding the need foremergency surgical intervention in patientswith acute ascending aortic dissection(Stanford type A), but the optimal treat-ment strategy for those with acute Stanfordtype B aortic dissection remains somewhat
controversial. Wheat and associates1,2 recommended medi-
cal treatment, but in 1970 Daily and colleagues3 from Stan-
ford concluded that there was no major difference in early
outcome between patients treated medically and those
treated surgically. Most groups today favor a complication-
specific approach, reserving surgical replacement of the
descending aorta for patients with rupture, organ ischemia,
refractory pain, uncontrollable hypertension, sizable dilata-
tion of the false lumen, or other life-threatening condi-
tions.4-8 On the other hand, our group9 has advocated con-
sideration of early operation for selected patients with acute
Stanford type B aortic dissection who are younger and
relatively good operative candidates, irrespective of the
presence or absence of complications.10,11 If operation is
successful, these individuals theoretically would be at lower
risk of sustaining late dissection-related aortic complica-
tions or requiring late aortic reoperation than would patients
treated medically. Whether this proposition is valid has
remained a matter of debate because of the relatively small
numbers of patients treated for acute Stanford type B aortic
dissection each year at any given hospital (even tertiary
referral centers).11 Further, the introduction of percutaneous
interventional techniques to alleviate dissection-induced
distal ischemia (or thoracoabdominal malperfusion) has
shifted traditional surgical indications, with more patients
now being treated medically despite the presence of com-
plications that in the past would have prompted operative
treatment. This change has further complicated the deci-
sion-making dilemma. Superiority of one treatment method
over any other cannot be definitively established short of a
multicenter, prospective, randomized trial of medical versus
surgical treatment in patients with uncomplicated acute
Stanford type B aortic dissections, which is probably unre-
alistic. Even indirect evidence supporting this more aggres-
sive surgical approach remains elusive because of patient
selection and patient referral biases, as well as the hetero-
geneity of the study populations.9-11 Application of new
statistical tools, such as propensity score analysis, can help
to overcome some of these problems by reducing the entire
set of background characteristics to a single, composite
feature that appropriately summarizes the collection.12,13
This approach allows identification of patient subsets at
similar risk in which outcome can be rigorously compared,
thereby avoiding the fallacious conclusions that can be
reached when different treatment methods are used to treat
markedly dissimilar patient cohorts.
To explore this dilemma, we performed a retrospective
investigation focusing on three primary end points: overall
survival, reoperation, and freedom from late aortic compli-
cations or death. By means of propensity score analysis, we
identified comparable subsets of patients, which allowed
more meaningful analysis. With the recent advent of endo-
vascular stent grafting, it is important to establish what can
be expected with our conventional medical or surgical treat-
ment strategies to define which patients may benefit from
this new endovascular therapy in the future.
Methods
Patient Population
One hundred eighty-nine patients (130 male and 59 female pa-
tients) with acute type B aortic dissection constitute the basis for
this report. Patients with intramural hematoma (with or without an
TABLE 1. Clinical characteristics at presentation for all 189
patients with acute type B aortic dissections, subdivided
into those treated medically and those who underwent
early operation
Medical Surgical 2 P value
Total (No.) 122 (65%) 67 (35%)
Age (y, mean  SD) 62 13 62 12
Sex (No.)
Male 83 (68%) 47 (70%)
Female 39 (32%) 20 (30%)
Previous dissection (No.) 2 (2%) 5 (8%) .043
Previous surgery (No.) 16 (13%) 9 (13%)
Hypertension 98 (80%) 46 (69%)
Coronary artery disease* (No.) 23 (19%) 13 (19%)
CHF 11 (9%) 1 (2%) .042
Smoking 68 (59%) 33 (55%)
Pulmonary disease† 31 (25%) 9 (13%) .054
Liver disease‡ 2 (2%) 1 (2%)
Diabetes 5 (4%) 2 (3%)
Stroke 11 (9%) 3 (5%)
Rupture 6 (5%) 19 (29%)
Visceral ischemia§ 34 (28%) 18 (27%)
Renal dysfunction 40 (33%) 19 (28%)
Peripheral pulse deficit¶ 28 (23%) 18 (27%)
Arch extension 6 (5%) 20 (30%) .001
Site of tear
None 5 (4%) 0 (0%)
Unknown 3 (3%) 4 (6%)
Arch 2 (2%) 7 (11%) .02
Descending aorta 109 (89%) 55 (82%)
Abdominal aorta 3 (2%) 1 (2%)
*As indicated by a previous diagnosis of coronary disease or myocardial
ischemia or infarction.
†Diagnosis of chronic obstructive pulmonary disease or significant lung
ailment.
‡Total bilirubin greater than 2.0 mg/dL at the time of diagnosis.
§Compromised arterial perfusion of any intra-abdominal organ diagnosed
by angiography, computed tomography, or magnetic resonance imaging.
Compromised renal perfusion by angiography, acute anuria, renal infarc-
tion or serum creatinine level of at least 3 mg/dL or blood urea nitrogen of
at least 40 mg/dL.
¶Loss of blood flow to extremities as documented by physical examination,
angiography, or computed tomography.
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associated penetrating aortic ulcer) were excluded, as were those
undergoing endovascular stent-graft treatment. One hundred twen-
ty-two patients were treated medically (1972-1999) and 67 patients
were treated surgically (1963-1999); patients treated nonsurgically
between 1963 and 1972 were not identified (Figure 1). The vast
majority of patients, irrespective of mode of therapy, were cared
for on the cardiovascular surgery service. The diagnosis of dissec-
tion was confirmed with aortography, computed tomography, mag-
netic resonance imaging, transthoracic or transesophageal echo-
cardiography, surgical findings, or autopsy reports. Dissections
were classified according to the Stanford system, as proposed in
1970.3 Dissections without ascending aortic involvement were
type B, even if some degree of retrograde arch involvement was
present. If the ascending aorta proximal to the level of the innom-
inate artery was involved, it was a Stanford type A, and the patient
was excluded from this analysis. All patients had dissection diag-
nosed within 14 days of the onset of symptoms. Clinical data were
obtained retrospectively through chart review, and current fol-
low-up was obtained by telephone or written communication.
Follow-up was 98% complete, extended to a maximum of 19 years
(mean 4.5  4.7 years), and totaled 842 patient-years.
Table 1 summarizes the clinical characteristics of the two
groups. Mean ( SD) patient age was 62 13 years (range, 25-88
years) and was nearly identical for the medical and the surgical
groups. Twenty-five patients (13%) had a history of previous
cardiac or aortic surgery: 13 (7%) had undergone a previous
sternotomy, and 7 (4%) had undergone an operation for previous
aortic dissection (5 with acute type A, 1 with acute type B [this
patient had a subsequent acute redissection of the descending
aorta], and 1 with chronic type A). The patients in the medical
group had higher incidences of renal and pulmonary disease,
congestive heart failure (CHF), and stroke. These factors, alone or
in combination, served as relative contraindications to surgical
therapy whenever possible. Rupture, which occurred 3 times more
frequently in the surgical group, constituted the main operative
indication in 28% of cases. Peripheral arterial or visceral ischemia
was present in 23% to 28% of patients in both groups.
In this series, the primary intimal tear was usually located in the
descending aorta just distal to the left subclavian artery (87%),
whereas 9 patients (5%) had an arch tear, 3 (2%) had the primary
intimal tear in the abdominal aorta, and 7 (4%) had no primary
intimal tear identified (Figure 2). Acute dissections originating in
the arch were rare, but they are a highly lethal problem.14 Extent
of dissection has been implicated previously as a predictor of high
risk for death. In this study, the descending aorta alone was
involved in 45 cases (24%); the descending and abdominal aorta
were involved in 117 cases (62%); the arch and descending aorta
were involved in 11 cases (6%); the arch, descending, and abdom-
inal aorta were involved in 14 cases (7%); the arch only was
involved in 1 case (1%); and the abdominal aorta was involved in
1 case (1%). There was no significant difference between the
medical and surgical groups with respect to the extent of dissec-
tion.
Patient Treatment
Medical therapy. All patients were treated in the intensive care
unit with aggressive blood pressure control with intravenous va-
sodilators and negative inotropic therapy, consisting primarily of
-blockade (esmolol and labetalol are the current preferred intra-
venous agents, subsequently transitioning to oral labetalol or meto-
prolol). Pain in most cases resolved with adequate blood pressure
control. Failure of medical therapy, defined as intractable pain
despite optimal antihypertensive regimen, uncontrollable hyper-
tension, rupture or leak, or progressive expansion of the false
lumen, prompted consideration of operation. Additionally, 6 pa-
tients since 1992 with uncomplicated dissections were judged to be
good operative candidates and underwent urgent open graft re-
placement of the descending aorta. Patients before 1992 with
thoracoabdominal malperfusion syndromes (visceral or renal isch-
emia or peripheral arterial compromise) usually were operated on.
Later, interventional radiologic catheter techniques became avail-
able for dissection flap fenestration and true lumen stenting.15
Surgical treatment. Through a left posterolateral thoracotomy
and with either partial (femorofemoral) cardiopulmonary bypass or
(in the last decade) total cardiopulmonary bypass and profound
hypothermic circulatory arrest, a short segment of the descending
thoracic aorta containing the most severe injury and whenever
Figure 1. Patient distribution by year according to whether they were treated medically (white bars) or surgically
(black bars).
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possible the primary intimal tear was replaced with a double
velour-woven Hemashield Dacron graft (Medi-Tech; Boston Sci-
entific Corporation, Boston, Mass). Because these were acute
dissections, the dissected walls of the aorta proximally and distally
were reapproximated with layers of polytetrafluoroethylene felt, or
Bioglue (CryoLife Inc, Kennesaw, Ga) since 1999, such that distal
flow into the reconstructed aortic true lumen was restored. In most
cases only 5 to 10 cm of the proximal descending thoracic aorta
was replaced. Rarely, ligation of the destroyed (or thrombosed)
aorta was performed, followed by axillofemoral bypass grafting or
an ascending aortic to abdominal aortic extra-anatomic bypass
graft (thromboexclusion). Few abdominal aortic surgical fenestra-
tions were carried out as a primary procedure before 1992.
Negative inotropic drug treatment was advised indefinitely,
even for normotensive patients, to minimize the incidence of late
redissection, aortic rupture, and false lumen aneurysmal enlarge-
ment.9,11,16 Early postoperative monitoring for all patients included
serial abdominal, neurologic, and pulse examinations to detect
visceral, limb, or spinal ischemia. If suspected, the diagnosis was
confirmed radiologically, and surgical (before 1992) or interven-
tional catheter fenestration and stenting was performed.15 After
discharge, it was recommended that all patients undergo serial
aortic surveillance with annual computed tomographic or magnetic
resonance imaging scans, but strict compliance with this recom-
mendation could not be ensured because most patients were re-
ferred from long geographic distances and were covered by a wide
variety of health care provider systems.
Statistical Methods
Preliminary analysis of the baseline data included 2 testing to
detect significant differences between the two treatment groups.
The main objective of the study was to assess whether there was
any benefit of surgical rather than medical therapy for patients with
acute Stanford type B aortic dissections by using statistical meth-
ods that would help neutralize the patient selection bias inherent in
this retrospective investigation. Variability of continuous data was
expressed as mean  SD, that of important fractions or ratios was
expressed as [mean  half the extent of the 70% confidence
interval (CI)], and that of actuarial or actual estimates was ex-
pressed as  SEM, roughly equivalent to the 70% CI.
A total of 21 preoperative characteristics or dissection-related
complications (independent variables) were analyzed for their pos-
sible influence on death at any time, incidence of reoperation, and
late aortic-related complications or death (dependent variables;
Table 2). Early mortality was defined as death within 30 days of
treatment or during the same hospitalization regardless of time.
The categoric variable extent of dissection involvement was con-
verted to a binary variable (arch extension) if the arch was in-
volved. Predictors of outcome for the entire group were identified
with Cox proportional hazards analysis and expressed as hazard
ratios (HRs) and their 95% CIs.
To generate propensity scores reflecting the probability of
receiving medical or surgical treatment, all independent variables
were entered into a univariable logistic regression model, with type
of treatment as the dependent variable and ignoring outcome.
Significant variables (P  .05) were entered into a stepwise
logistic multivariable regression model to discriminate those with
the greatest power in predicting treatment type. Of the variables
used to create the propensity model, only pulmonary disease
(favoring medical treatment) and rupture, arch dissection, and
previous dissection (favoring operative intervention) were signif-
icant in the logistic multivariable regression model. A propensity
score was then calculated from the logistic equation for each
patient. The patients were then divided into 5 propensity-matched
quintiles (Figure 3). Quintiles III, IV, and V included patients more
likely to receive surgical therapy because of the presence of
rupture, shock, arch involvement, or previous dissection; these 47
patients (11 medical, 36 surgical), represented 25% of the patient
sample. The remaining two quintiles (I and II) contained 142
patients (75% of the total patient sample) who did not have any
Figure 2. Sites of primary intimal tear in groups treated medically and surgically.
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compelling surgical indications and were well matched. This rel-
atively homogeneous cohort of 111 medically treated and 31
surgically treated patients was analyzed further to determine
whether there were any differences in outcome between the two
treatment approaches.
Actuarial estimates of survival, freedom from reoperation, and
freedom from late dissection-related aortic complications or death
were performed with the Kaplan-Meier method. In the case of
freedom from reoperation, which is a nonfatal event, actual (or
observed cumulative frequency) probabilities of reoperation were
also calculated. Statistical comparisons between the actuarial
curves were performed with the log-rank test.
Results
Of the 189 patients, 122 (64%) were treated medically and
67 (36%) underwent an open operative procedure. Figure 1
illustrates patient distribution by type of treatment across
time. A relatively stable number of surgical patients were
seen each decade, and until the 1990s this number was
roughly equal to the number treated medically. After 1990,
however, a large increase in the medical group occurred,
with 43% (n  37/86) of these patients undergoing adjunc-
tive interventional dissection flap fenestration and stenting
for thoracoabdominal malperfusion (23 true lumen stents
and 14 fenestrations) in this era. The advent of these per-
cutaneous techniques accounts for this shift in operative
indications by allowing many complicated cases to avoid
operation. In addition, two surgical patients (6%) required
catheter interventions for ischemic complications after the
operation.
The predictors of death at any time for the entire patient
cohort were identified with a backward, stepwise multiva-
riable Cox proportional hazards analysis. In terms of the
magnitude of the adverse clinical impact on survival, shock
(HR 14.9, 95% CI 4.7-44.5, P .001) and visceral ischemia
(HR 10.9, 95% CI 3.9-30.3, P .001) dominated by a large
margin (Table 3). Six other variables roughly doubled the
probability of death: arch involvement (HR 2.5, 95% CI
1.5-4.3, P  .001), rupture (HR 2.5, 95% CI 1.4-4.3, P 
.001), stroke (HR 2.4, 95% CI 1.2-4.7, P  .01), previous
sternotomy (HR 2.4, 95% CI 1.2-4.9, P  .019), coronary
artery disease (HR 2.2, 95% CI 1.4-3.6, P  .001), and
pulmonary disease (HR 2.1, 95% CI 1.3-3.4, P  .003).
Female sex, although a significant independent determinant
of death, had only a modest effect on survival (HR 1.6, 95%
CI 1.0-2.4, P  .035). Year of admission, age, treatment
mode (medical vs surgical), and renal dysfunction did not
emerge as significant predictors of death. Even though year
TABLE 2. Patient characteristics and disease-related vari-























*As indicated by a previous diagnosis of coronary disease or myocardial
ischemia or infarction.
†Diagnosis of chronic obstructive pulmonary disease or significant lung
ailment.
‡Total bilirubin greater than 2.0 mg/dL at the time of diagnosis.
§Compromised renal perfusion by angiography, acute anuria, renal infarc-
tion or serum creatinine level of at least 3 mg/dL or blood urea nitrogen of
at least 40 mg/dL.
Compromised arterial perfusion of any intra-abdominal organ diagnosed
by angiography, computed tomography, or magnetic resonance imaging.
¶Loss of blood flow to extremities as documented by physical examination,
angiography, or computed tomography.
**0, No tear identified; 1, ascending aorta; 2, arch; 3, descending aorta; 7,
abdominal aorta.
††1, Arch involvement; 0, no arch involvement.
‡‡History of previous cardiac or vascular surgery.
§§0, No dissection; 1, acute type A dissection; 2, acute type B dissection;
3, chronic type A dissection; 4, chronic type B dissection.
CHF or ischemia according to angiogram, history, or electrocardiogram.
TABLE 3. Statistically significant independent variables
that predicted a higher likelihood of death (early or late) by
Cox propensity hazards analysis
 (HR) 95% CI P value
Shock 14.5 4.7-44.5 .001
Visceral ischemia* 10.9 3.9-30.3 .001
Arch extension† 2.5 1.5-4.3 .001
Rupture 2.5 1.4-4.3 .001
Stroke 2.4 1.2-4.7 .01




Pulmonary disease§ 2.1 1.3-3.4 .003
Sex 1.6 1.0-2.4 .035
*Compromised arterial perfusion of any intra-abdominal organ diagnosed
by angiography, computed tomography, or magnetic resonance imaging.
†1, Arch involvement; 0, no arch involvement.
‡As indicated by a previous diagnosis of coronary disease or myocardial
ischemia or infarction.
§Diagnosis of chronic obstructive pulmonary disease or significant lung
ailment.
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of presentation was not a significant independent predictor
of death, the early mortality risk did fall gradually in the
surgical group, from 57%  19% during the 1960s to 27%
 10% in the 1990s (Figure 4). Conversely, no such trend
toward lower early mortalities across time was observed in
the medical group.
With respect to the dependent variables of reoperation
and freedom from late aortic complications or death, the
only independent predictor that emerged from the Cox
multivariable analysis was Marfan syndrome. For reopera-
tion, the HR for Marfan syndrome was 6.3 (95% CI 2.4-
16.8, P  .001); for the combined end point of late aortic
complications or death, the HR was 5.9 (95% CI 2.5-114.3,
P  .001).
For the propensity score calculations, univariate logistic
regression analysis identified CHF and pulmonary disease
as predictors of medical therapy, whereas rupture, arch
extension, previous (acute type A) dissection, and arch
primary intimal tear predicted a higher likelihood of surgi-
cal intervention. The stepwise logistic multivariable regres-
sion model indicated that pulmonary disease, rupture, arch
extension, and previous dissection significantly predicted
whether the patient was more likely to be treated medically
or surgically. These variables were entered into a logistic
equation for each individual patient to compute the propen-
sity scores. The entire population was then divided into
propensity-matched quintiles to balance these characteris-
tics. Quintiles III, IV, and V contained 47 patients who were
most likely to be operated on because of the presence of
rupture, shock, or arch extension (only 36 were actually
Figure 3. Quintiles I and II of 5 propensity-matched quintiles were used for further analysis of determinants of three
primary outcome variables among patients treated medically (white bars) or surgically (black bars). These two
quintiles included 142 patients, or 75% of entire sample. Note how numbers of patients treated either way were
unbalanced in these quintiles to accomplish balancing of risk. Patients in quintiles I and II were comparable but
were not necessarily low-risk patients, with many having thoracoabdominal malperfusion and other serious
complications (see Table 3). Quintiles III through V (25% of patients) were not well matched, and most required
operation.
Figure 4. Early (30-day) mortalities as function of time (decades) and broken down into medical (white bars) and
surgical (black bars) subgroups. Variability in mortality is indicated as  half extent of 70% CI.
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offered operation). Therefore these patients were not ana-
lyzed further. The 142 patients in quintiles I and II were
well matched but did not necessarily constitute a low-risk
subpopulation. Because of the small numbers of surgical
patients in quintiles I and II (4 in quintile I and 27 in quintile
II, these two quintiles were combined for a total of 142
patients (111 medical and 31 surgical) and examined fur-
ther. The effectiveness of the propensity score matching was
validated in that there were no significant differences be-
tween these medical and surgical patients (Table 4). More
detailed analyses focusing on treatment method were then
performed on the 142 patients within quintiles I and II with
respect to survival, freedom from reoperation, and freedom
from late dissection-related complications or death.
Actuarial survival estimates for all patients at 1, 5, 10,
and 15 years were 71%, 60%, 35%, and 17%, respectively.
Survivals at these same times were 85%  4%, 71%  5%,
38%  6%, and 20%  6% for the medically treated
patients, versus 67%  6%, 63%  6%, 39%  6%, and
12%  5% for the surgical cohort (P  .11), as shown in
Figure 5, A, which also contains the survival curve for an
age- and gender-matched US population. There was no
significant difference between the treatment groups in actu-
arial reoperation rates at these intervals (94% 2%, 86%
4%, 83% 7%, and 62% 14% for the medical group and
96% 3%, 87% 6%, 83% 7%, and 83% 7% for the
surgical group; Figure 5, B). Calculating the freedom from
reoperation in actual terms shifted the curves upward (as
TABLE 4. Patient characteristics categorized by propensity-matched quintiles




2 P valueNo. % No. % No. % No. %
Total 111 31 11 36
Hypertension 88 79 22 71 NS 10 91 24 67 NS
Coronary artery
disease*
19 17 6 19 NS 4 36 7 19 NS
Pulmonary disease† 29 26 4 13 NS 2 18 5 14 NS
Liver disease‡ 2 1.8 0 0 NS 0 0 1 3 NS
Renal dysfunction§ 38 34 5 16 NS 2 18 14 39 NS
Diabetes mellitus 4 4 0 0 NS 1 9 2 6 NS
Smoking 63 57 17 55 NS 5 46 16 47 NS
Rupture 0 0 0 0 NS 6 55 19 53 NS
Shock 0 0 1 3 NS 0 0 6 17 NS
Visceral ischemia 31 27 6 19 NS 3 27 12 33 NS
Stroke 8 7 1 3 NS 3 27 2 6 .041
Peripheral pulse deficit¶ 25 23 6 19 NS 3 27 12 33 NS
Arch extension** 0 0 0 0 NS 3 27 11 31 NS
Previous surgery†† 11 10 5 16 NS 5 46 4 11 .011
Previous dissection‡‡ 1 1 1 3 NS 1 9 4 11 NS
CHF 11 10 0 0 NS 0 0 1 3 NS
Marfan syndrome 6 5 3 10 NS 0 0 2 6 NS
Cardiac disease§§ 4 4 0 0 NS 0 0 0 0 NS
Site of tear
None 4 4 0 0 NS 1 9 0 0 NS
Unknown 2 2 2 7 NS 1 9 2 6 NS
Arch 0 0 1 3 NS 2 18 6 17 NS
Descending aorta 102 92 28 90 NS 7 64 27 75 NS
Abdominal aorta 3 3 0 0 NS 0 0 1 3 NS
Quintiles 1 and 2 were equally likely to be treated either surgically or medically and were relatively well matched in terms of risk. These two quintiles were
combined (total of 142 patients) for further analysis. NS, Not significant.
*As indicated by a previous diagnosis of coronary disease or myocardial ischemia or infarction.
†Diagnosis of chronic obstructive pulmonary disease or significant lung ailment.
‡Total bilirubin greater than 2.0 mg/dL at the time of diagnosis.
§Compromised renal perfusion by angiography, acute anuria, renal infarction or serum creatinine level of at least 3 mg/dL or blood urea nitrogen of at least
40 mg/dL.
Compromised arterial perfusion of any intra-abdominal organ diagnosed by angiography, computed tomography, or magnetic resonance imaging.
¶Loss of blood flow to extremities as documented by physical examination, angiography, or computed tomography.
**Retrograde dissection involving the aortic arch but stopping short of the proximal limit of the innominate artery.
††History of previous cardiac or vascular surgery.
‡‡0, No dissection; 1, acute type A dissection; 2, acute type B dissection; 3, chronic type A dissection; 4, chronic type B dissection.
§§CHF or ischemia according to angiogram, history, or electrocardiogram.
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expected, given the strong competing risk of death) and
further emphasized the lack of any difference between them.
The estimates of actual freedom from reoperation at 1, 5,
and 10 years were 93%  2%, 91%  3%, and 89%  4%,
respectively, for medically treated patients, versus 97% 
2%, 92%  4%, and 90%  4% for the surgical group
(Figure 5, C). Finally, the actuarial estimates of freedom
from late aortic-related complications or death at 1, 5, 10,
and 15 years were 83%  4%, 77%  4%, 59%  8%, and
51% 11%, respectively, in the medical group, versus 83%
 5%, 67%  7%, 64%  8%, and 52%  12% in the
surgical group (P  .79; Figure 5, D). The causes of death
are listed in Table 5. Combining deaths from progression of
dissection or rupture, those that were sudden and unex-
plained (which could possibly have been due to aortic
rupture), and those for which a cause was unknown, 34% of
the medical and 31% of the surgical groups could theoret-
ically have died of an aortic complication. Comorbidities
such as CHF, renal failure, cancer, and stroke accounted for
50% of the deaths in the medical subset, compared with
40% of the surgical patients.
Turning to the results among the 142 comparable pa-
tients in quintiles I and II, the actuarial and actual curves are
depicted in Figure 6. Survivals at 1, 5, 10, and 15 years were
85%  4%, 71%  5%, 38%  7%, and 20%  7%,
respectively, in the medical subset, versus 67%  9%, 63%
 9%, 39%  10%, and 12%  7% in the surgical subset
(P  .47), as shown in Figure 6, A. Again, the expected
survival curve for an age- and gender-matched US popula-
tion is illustrated for perspective. Actuarial freedoms from
reoperation in quintiles I and II at 1, 5, 10, and 15 years
were 93% 3%, 88% 4%, 83% 7%, and 62% 14%,
respectively, for medically treated patients and 96%  4%,
86%  8%, 86%  8%, and 86%  8% for surgically
treated patients (P  .62; Figure 6, B). Actual freedoms
from reoperation again were similar (Figure 6, C). Actual
freedoms from reoperation in quintiles I and II at 1, 5, 10,
and 15 years were 94%  2%, 90%  3%, 87%  4%, and
82%  5%, respectively, for medically treated patients and
97%  3%, 90%  6%, 90%  6%, and 90%  6% for
surgically treated patients (P  .62). Finally, examination
of survivals free of late aortic-related complications (includ-
ing reoperation) showed no significant differences between
the subsets, with 88%  3%, 82%  4%, 62%  9%, and
53%  11% of medically treated patients surviving free of
aortic complications at 1, 5, 10, and 15 years, respectively,
versus 92%  5%, 68%  10%, 68%  10%, and 49% 
18% of surgically treated patients (P  .78; Figure 6, D).
For all three end points, inspection of Figures 5 and 6
reveals that the curves were even closer together for the
comparable quintile I and II patients than for all patients.
This verifies that the propensity score selection process was
valid.
The early postoperative mortality for surgical patients in
quintiles I and II was 20% during all 36 years of the study,
which was lower than the mortality for all patients, reflect-
ing the impact of patient selection factors as elucidated by
the propensity score analysis. Since 1992, none of the 6
surgical patients in quintiles I and II died within 30 days,
yielding a surgical mortality of 0 for this small sample. This
was due to some extent to the fact that after 1992 desper-
ately ill patients with thoracoabdominal malperfusion syn-
dromes were treated with percutaneous interventional cath-
eter techniques coupled with conventional medical therapy.
Discussion
The controversy surrounding the optimal therapy for aortic
dissections dates back to the 1960s, when DeBakey and
colleagues17 published a series of 179 patients treated sur-
gically. Given that this report was 36 years ago, the 21%
early mortality and 5-year survival of 50% were impressive.
After comparing their data with a large number of patients
treated nonoperatively by Hirst and coworkers,18 with a
survival of 7% at 1 year, DeBakey and colleagues17 con-
cluded that all patients with aortic dissection should un-
dergo surgical intervention. Nonetheless, breakdown of
these data reveals a highly skewed patient population: 121
(68%) of the patients had a chronic dissection, and most had
DeBakey type III dissections. In contrast, a few years later
Wheat and associates2 advocated a selective approach to the
treatment of patients with acute aortic dissection on the
basis of the observation that surgery carried a 25% early
mortality, compared with 16% for pharmacologic therapy.
They believed that rupture resulted from continued dissec-
TABLE 5. Causes of the late deaths among the 189 patients
subdivided according to treatment method
Medical Surgical
No. % No. %
Dissection rupture or extension 8 18 3 10
Sudden unexplained death 2 5 4 14
Arrhythmia 1 2 2 7
Myocardial infarction 2 5 3 10
CHF 5 11 2 7
Prosthetic valve structural valve dysfunction 1 2 0 0
Renal failure 3 7 1 3
Respiratory failure or pneumonia 5 11 2 7
Stroke 3 7 0 0
Anticoagulant hemorrhage 0 0 1 3
Multisystem organ failure 1 2 1 3
Sepsis 3 7 0 0
Malignancy 3 7 2 7
Suicide or accident 1 2 1 3
Gastrointestinal disease 0 0 1 3
Unknown 5 11 2 7
Other 1 2 2 7
Total 44 27
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tion caused by high blood pressure and the impulse of
myocardial contractility and recommended a pharmacologic
regimen that decreased not only systemic pressure but also
the myocardial impulse (aortic dp/dt); this gave rise to
modern anti-impulse therapy. Rupture, impending rupture,
overwhelming aortic insufficiency, and dissection-related
ischemic complications constituted their only operative in-
dications. In 1970 Daily and associates3 first reported on
how important it was (with respect to both prognosis and
choice of treatment method) to differentiate between dis-
sections that involve the ascending aorta and those that do
not; this article introduced the Stanford type A and B
dissection classification system, which is independent of the
site of the primary intimal tear. For 30 years the consensus
Figure 5. A, Actuarial survivals for all patients subdivided according to treatment mode (triangles, medical,
squares, surgical). For perspective, this graph also portrays survival curve for age- and gender-matched US
population (circles); this indicates that only approximately 35% of patients this age can be expected to be alive
20 years later. B, Estimates of actuarial freedom from reoperation for all patients subdivided according to treatment
mode (triangles, medical, squares, surgical).
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opinion has been that patients with acute type B dissections
should be treated medically unless life-threatening compli-
cations are present. Fann and coworkers19 reported the
Stanford results for 3 decades. Early mortalities varied
considerably across time (13%  12% to 57%  20%),19
with better results more recently. Another earlier Stanford
report showed that the operative risk for patients with an
acute type B aortic dissection was markedly influenced by
the presence of several risk factors, including renal or vis-
ceral ischemia, aortic rupture, and older age.9 Operative
mortality climbed from 23% to 80% if renal or visceral
ischemia was present and from 21% to 71% if aortic rupture
had occurred.16 These observations were corroborated by
our current analysis; moreover, a trend toward progressively
lower early mortality risk across time was apparent for
surgical patients but not for those treated medically (Figure
4). Since catheter interventional procedures for malperfu-
sion were introduced in 1992, this has been even more
Figure 5. Cont’d. C, Freedoms from reoperation for all patients expressed in actual (or observed cumulative
frequency) terms subdivided according to treatment mode (triangles, medical, squares, surgical). D, Actuarial
freedom from late aortic-related complications or death for all 189 patients subdivided according to treatment
mode (triangles, medical, squares, surgical).
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apparent, with no early deaths among 6 quintile I and II
patients treated with open graft replacement of the descend-
ing thoracic aorta.
The long-term survivals reported by Fann and col-
leagues19 for patients with acute B dissections were 56%,
48%, 29%, and 11% at 1, 5, 10, and 15 years, respectively.
Fann and colleagues19 had previously hypothesized that this
sobering prognosis might be due to suboptimal serial imag-
ing surveillance after the operation, which theoretically
would detect potential downstream aortic problems before
rupture or death; however, in our analysis the causes of late
death (Table 5) were similar in the two treatment groups,
with most patients dying of underlying comorbidities, as the
survival curves for a matched US population in Figures 5, A,
and 6, A, reflect.
Recently, Schor and associates5 from Griepp’s group at
Mt Sinai Medical Center reported on a group of 68 patients
with acute type B dissections between 1985 and 1995
Figure 6. A, Actuarial survival for the 142 comparable patients in quintiles I and II subdivided according to
treatment mode (triangles, medical, squares, surgical), along with expected survival curve for age- and sex-
matched US population (circles). B, Actuarial freedom from reoperation in quintiles I and II subdivided according
to treatment mode (triangles, medical, squares, surgical).
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treated with a selective approach. Indications for operation
during the acute phase included rupture or substantial aortic
dilatation. Malperfusion, initially an operative indication,
had since 1993 been treated with balloon fenestration at
their institution.5 Patients without any of these characteris-
tics were treated medically. Overall actuarial survival esti-
mates at 1 and 5 years were 92%  4% and 82%  8%,
respectively, and were similar in the two treatment groups
(93%  6% and 68%  14% for the surgical group and
96%  3% and 93%  4% for the medical group). Oper-
ative morbidity, however, was considerable, because 59%
of patients had one or more serious complications. Schor
and associates5 attributed their success to the selected nature
of their patient population, coupled with improved spinal
cord protection and better perioperative care. Lansman and
coworkers8 updated this Mt Sinai experience in 1999.
Among 29 patients with acute type B aortic dissection
operated on during a 12-year interval (1985-1997) with this
selective approach, there were no early postoperative deaths
and only 1 case of paraplegia (4%).8 These commendable
Figure 6. Cont’d. C, Actual freedom from reoperation for the patients in quintiles I and II subdivided according to
treatment mode (triangles, medical, squares, surgical). D, Actuarial freedom from late aortic-related complications
or death in quintiles I and II subdivided according to treatment mode (triangles, medical, squares, surgical).
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results parallel our experience after 1992, confirming the
influence of assiduous patient selection. Longer follow-up is
needed, however, to establish conclusively whether this
approach affects the long-term natural history of this dis-
ease.
In a large series from Bern, Switzerland, Gaze and col-
leagues20 reported a 21% surgical mortality, versus 18% for
medical therapy. Because 30% of patients subsequently
required operation, they concluded that surgical indications
should be expanded to include younger patients. They rec-
ommended early intervention for patients with Marfan syn-
drome, arch involvement,11,14 and expectation of poor med-
ical compliance.21,22
The series reported here represents one of the largest
groups of patients treated for acute type B dissection at a
single institution, but a previous study combining patients
from Stanford and Duke23 addressed the same question. The
problem faced at that time was the same. How does one
define comparable cohorts? Glower and colleagues23 stud-
ied patients with acute or chronic type B dissections with
multivariable analysis. Group I was defined as the entire 136
subjects in the study. Patients without compelling indica-
tions for emergency surgery constituted group II. From this
group, individuals who had no severe cardiac or renal dis-
ease comprised group III, a low-risk group that theoretically
could have been treated either way. For all patients, the
significant determinants of overall mortality were aortic
rupture, other dissection complications, increasing age, and
cardiac disease. Type of treatment did not emerge as a
significant predictor in any of the three groups. In the
low-risk group III, the only predictor of mortality was
advanced age. Survival estimates for the entire group at 1, 5,
and 10 years were 80%, 59%, and 30%, respectively, for
medically treated patients, versus 75%, 52%, and 25% for
surgical patients (P  NS). When the low-risk cohort
(group III) was analyzed, survivals at the same intervals
were 94%, 87%, and 32% for the medical subgroup, versus,
90%, 80%, and 50% for those undergoing operation (P not
significant).
Subsequent analysis of this same database by Miller11
focusing on the acute dissections framed the argument for
offering operation to more young patients without compli-
cations with acute type B dissections. Focusing only on the
89 patients with acute Stanford type B aortic dissections,
there were 30 patients remaining after exclusion of those
with life-threatening complications (n  24) and those who
were not good surgical risks on the basis of other medical
problems (n  35). This low-risk cohort of patients was
considered suitable for either medical or surgical therapy.
Of these, 19 were treated medically and 11 were treated
surgically. The early mortality for the medical patients was
16%, versus 9% for the surgical patients. This subset of
patients without complications who otherwise are reason-
able operative candidates probably is representative of the
29 patients operated on at Mt Sinai8 with no deaths. We
continue to advocate that such carefully selected patients be
considered for early operation.
This study reviews our entire experience for a period of
36 years with the treatment of patients with acute Stanford
type B aortic dissection. The obstacles, as previously en-
countered by our group and others, are the heterogeneous
nature of the study populations, inherent selection and re-
ferral biases, continuous evolution of established treatment
methods, and the advent of new percutaneous interventional
therapies. Analysis of the entire experience demonstrated a
trend toward lower surgical mortality risk through the years,
from 57% between 1963 and 1969 to 27% between 1990
and 1999 (Figure 4). Our most recent experience is more
encouraging (no early surgical deaths in 6 patients without
complications operated on after 1992); this may be due in
part to the introduction of percutaneous interventional re-
vascularization, which has increased the number of ex-
tremely sick patients undergoing medical treatment.
To address selection bias and the heterogeneous patient
population, we used propensity score analysis to discrimi-
nate a group of patients that allowed more meaningful
comparison of medical and surgical therapies. This group
(quintiles I and II) included 142 patients (31 surgical and
111 medical), which were well matched. Analysis of these
comparable patients in quintiles I and II showed that late
survivals in the medical and the surgical groups were re-
markably similar. For the 31 patients in quintiles I and II
who were operated on, the operative mortality was 20%.
The long-term results reported here are consonant with
those reported previously by Glower and colleagues23 in the
Duke-Stanford database study. Unfortunately, this sobering
prognosis seems to reflect the fact that most patients who
sustain an acute type B aortic dissection have other life-
limiting illnesses (Figures 5, A, and 6, A). We therefore
specifically looked at the rates of reoperation and dissec-
tion-related complications in quintiles I and II. Survivals
free of dissection-related complications (Figure 6, D) at 5
and 10 years were 82% and 62% in the medical group and
68% and 68% among the surgical patients (P  .8). The
difference in survival free of reoperation (Figure 6, B and C)
also failed to reach statistical significance, although the
curves for the surgical group stabilized after 3 years at 86%,
whereas that for the medically treated patients continued to
decline to 62% after 10 years. It is important to remember,
however, that only small numbers of patients remained at
risk beyond 5 to 10 years.
In summary, these data indicate that medical therapy
appears to confer some survival advantage during the short
term (Figure 5, A), but this is not statistically significant;
other patient-related and dissection-related factors truly de-
termine outcome (Table 3). Furthermore, the comparable
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patients in quintiles I and II had an identical prognosis
whether treated medically or surgically (Figure 6, A). If
expected survivals among these comparable patients were
the same regardless of whether a patient was treated surgi-
cally or medically, these results can be interpreted two
completely different ways. One could logically infer that all
patients should be treated medically; conversely, but
equally logically, another observer could infer that all pa-
tients should be treated surgically. Because our surgical
experience with 6 patients without complications since 1992
and that at Mt Sinai with 29 patients8 between 1985 and
1997 have demonstrated that extremely low operative mor-
talities and morbidity rates are realistic, we interpret the
results of this analysis as justification for offering early
operation on a selective basis to more patients, even in the
absence of complications, including those with Marfan syn-
drome, younger patients, and those judged to be good op-
erative candidates. Indeed, Marfan syndrome was the only
significant independent predictor of reoperation or late aor-
tic complications or death. Overall, early operation certainly
did not provide normal life expectancy (Figures 5, A, and 6,
A), but on the basis of contemporary results here and else-
where,8 we believe that consideration of early operation
may potentially reduce the need for reoperation and perhaps
the incidence of fatal events. Only more follow-up of pa-
tients currently surviving early operation will answer this
question in the future.
Percutaneous fenestration and stenting techniques to cor-
rect ischemic complications related to thoracoabdominal
malperfusion have become a valuable adjunct to both med-
ical and surgical therapy, but what is the role of endovas-
cular stent-grafts in the future for these patients? Recently
we showed that stent-grafts are associated with an early
mortality of 16% among patients with acute Stanford type B
aortic dissections who have life-threatening complica-
tions24; if treated conventionally with an emergency thora-
cotomy, these patients would be facing an early risk in the
range of 40%, or upward of 60% to 70% if treated medi-
cally.11,16,19,23 The effectiveness of stent-grafts for patients
with complicated acute Stanford type B aortic dissections,
however, must be confirmed in prospective randomized
trials in which this endovascular approach can be rigorously
compared with conventional open operation. A bigger un-
answered clinical question pertains to the patients with
acute Stanford type B aortic dissection who do not have
complications, for whom stent-grafts have also been used
successfully.25 To address this quandary, we strongly en-
dorse proceeding with multicenter randomized trials in
which medical therapy is compared head to head with
stent-grafting. Only such controlled trials can conclusively
provide the information that we need to guide our therapeu-
tic strategies in the future.
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Discussion
Dr Dave Fullerton (Chicago, Ill). This is a complex subject, and
all of us around the country have looked to Stanford during the last
several decades for guidance in how to treat these difficult prob-
lems. What Uman˜a and colleagues have provided us with today is
enlightening.
When I saw the title of the abstract, I assumed that it would
reinforce what most of us continue to teach: type B dissections
should be treated medically. The thought process behind that was
some data suggesting that outcomes were substantially better if
such patients were treated medically rather than surgically. I am
sure that this series reflected a bias of the worst patients getting
operated on. Nonetheless, Uman˜a and colleagues showed there
was really no difference in need for reoperation, no difference in
aortic or other complications, and, most impressively, really no
difference in survival when patients were treated medically or
surgically.
Because the patients undergoing surgery almost certainly rep-
resented the worst cases, yet surgical outcomes were not different
from medical outcomes, this really begs the question of whether
we should operate on these patients, rather than treat them medi-
cally. Dr Uman˜a, would you extrapolate on that a little bit?
Second, I know that your group has experience with the develop-
ment of the endovascular stent technology. You probably have
some experience in treating these patients off protocol. Could you
share some of that with us?
Dr Uman˜a. In terms of whether we should operate more on
these patients, I think that what we need to do is individually tailor
patient treatment. If you have a patient at low risk who has a
reasonable life expectancy and is a good operative candidate, our
belief is that you probably should operate if you can achieve an
operative mortality less than 5%. In those cases, the outcome
should be better. In looking at our own series during the last
decade those results are essentially reflected.
Regarding the stent grafts, we have published our experience
with use of stent grafts in complicated acute type B aortic dissec-
tion. Patients who would otherwise have a mortality of approxi-
mately 50% had an operative mortality of about 16%. These
stent-grafts can be used. This was a small patient group of only 19
patients, 16 of whom were treated at Stanford, and that study, as I
said, needs to be validated in a prospective fashion.
The question is, should we be using stent grafts for patients
without complications? I think the answer to that lies only in a
prospective randomized study, again comparing stent-graft and
medical treatment.
Dr Vaughn Starnes (Los Angeles, Calif). I want to add a sense
of Western Thoracic Surgical Association tradition to your nice
presentation, Dr Uman˜a. This is the 27th Western Thoracic Sur-
gical Association meeting, and you are a candidate for the Samson
resident prize. Dr Fullerton, who discussed the article at the
invitation of our program committee, was a recipient of this prize
11 years ago in 1990. We wish you well, and we look forward to
your being an invited discussant in years to come on the basis of
your accomplishments.
Dr Edward Verrier (Seattle, Wash). I think that this is an
important article, and I have a two-part question. Why do the
patients die every time? Mortality does not seem to be directly
related to thrombotic disease. Aren’t the preoperative risk factors
the predictors of long-term outcome, rather than the aortic disease
itself?
Dr Uman˜a. That is exactly right. If you look at the causes of
late death, we found that aortic-related deaths accounted only for
about 30% of those, whereas most patients died of their comor-
bidities, such as pulmonary disease, renal dysfunction, and under-
lying cardiac disease.
Dr Verrier. Now if we believe that, I will just make one more
extrapolation. Why should we change our current teaching on
therapy for acute type B dissection?
Dr Uman˜a. That is why I started by saying that if we are going
to change our practice, we should individually tailor it. We have to
customize it to the patient. If you have a patient who is young and
who has no cardiac disease or pulmonary disease (and I know that
they are rare, but the study from Mount Sinai includes 29 patients
with those characteristics), then you should probably operate on
them.
Dr Verrier. Would that group be the patients with Marfan
syndrome, then?
Dr Uman˜a. Not necessarily. It would probably include the
patients with Marfan syndrome, but it would not necessarily be all
patients with Marfan syndrome.
Dr Starnes. The third corollary to that question is, why does a
surgical group end up being at the same spot even though survival
does not go down in parallel. You have a higher mortality with
surgery at the time of surgery, and you would think that survivals
would go down in parallel if they were not related to the aortic
disease. That is why it remains so ambiguous in terms of how to
interpret these data.
Dr Uman˜a. This is something we have been discussing among
ourselves. We believe that if you can get rid of that operative
mortality, then your survival curve will come up 15 points and all
of a sudden your surgical group will stay up higher. What I
interpret your question to mean is that survival in the surgical
group of patients drops off acutely but then seems to be flatter, if
you will, than the medical curve. If you can get rid of the operative
mortality, then presumably your midterm or long-term results and
outcome are going to be better.
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